Stockscreener 앱 받기
23.04
1.05%
0.1866
Biohaven Ltd 주식(BHVN)의 최신 뉴스
UBS Adjusts Biohaven Price Target to $40 From $65, Maintains Buy Rating - marketscreener.com
Biohaven Is Now A Compelling Contrarian Play Before Troriluzole's FDA Verdict (NYSE:BHVN) - Seeking Alpha
Raymond James Financial Inc. Buys Shares of 37,033 Biohaven Ltd. (NYSE:BHVN) - Defense World
Finance Watch: Biohaven Gains Up To $600m In Fresh Capital - insights.citeline.com
An Intrinsic Calculation For Biohaven Ltd. (NYSE:BHVN) Suggests It's 47% Undervalued - simplywall.st
19,352 Shares in Biohaven Ltd. (NYSE:BHVN) Acquired by Renaissance Technologies LLC - Defense World
Oberland Capital’s $600 Million Investment in Biohaven - Global Legal Chronicle
Biohaven Ltd [BHVN] Director makes an insider purchase of 32,700 shares worth 1.0 million. - knoxdaily.com
Biohaven (BHVN) Projected to Post Earnings on Thursday - Defense World
Biohaven Ltd. (NYSE:BHVN) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Where are the Opportunities in (BHVN) - news.stocktradersdaily.com
Invesco Ltd. Raises Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven Ltd.’s Strategic Expansion and Financial Strength Bolster Buy Rating - TipRanks
Are Smart Investors Making the Right Decision? Biohaven Ltd (BHVN) - Sete News
BHVN’s Market Whiplash: -41.79% YTD Decline, -23.42% Plunge in 30 Days - investchronicle.com
Biohaven secures $600m financing as it awaits FDA prodrug decision - Yahoo
Biohaven (NYSE:BHVN) Given New $57.00 Price Target at Robert W. Baird - Defense World
Biohaven (BHVN) Secures Up to $600M Investment from Oberland Cap - GuruFocus
Biohaven secures up to $600 million from Oberland Capital By Investing.com - Investing.com Nigeria
Biohaven secures up to $600 million from Oberland Capital - Investing.com Australia
BHVN’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
Why BioHaven Stock Is Soaring Today - Mitrade
A Guide To The Risks Of Investing In Biohaven Ltd (BHVN) - knoxdaily.com
Biohaven Ltd. Receives Buy Rating Amid Strategic EU Resubmission and Positive FDA Outlook - TipRanks
Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland - Benzinga
Biohaven to receive investment of up to $600M by Oberland Capital - TipRanks
Biohaven announces investment of up to $600M - Hartford Business Journal
Financial Analysis: Biohaven Ltd (BHVN)’s Ratios Unveil Key Insights - DWinneX
Biohaven Announces Investment by Oberland Capital - Contract Pharma
Stride To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Biohaven Ltd. Secures $600M Investment from Oberland Capital - TipRanks
Biohaven Announces Investment Up To $600 Mln By Oberland Capital - marketscreener.com
Why Biohaven Ltd. Shares Are Tumbling - TipRanks
Biohaven Lands Major $600 Million Deal With Oberland Capital - Finimize
Biohaven Signs Deal for Investment of up to $600 Million by Oberland; Shares up Pre-Bell - marketscreener.com
Biohaven (BHVN) Price Target Cut by Baird Amid Regulatory Develo - GuruFocus
Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital - StreetInsider
Biohaven Lands Massive $600M Backing to Advance First-Ever Treatment for Rare Genetic Disease - Stock Titan
Biohaven Announces Investment up to $600 Million by Oberland Capital - The Malaysian Reserve
Biohaven (NYSE:BHVN) Upgraded at William Blair - Defense World
Biohaven (BHVN) Faces Market Setback After EMA Withdrawal - GuruFocus
Wells Fargo & Company MN Increases Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World
Biohaven share price undervaluing pipeline potential, says RBC Capital - Yahoo Finance
Why Biohaven Stock Plummeted by More Than 15% Today - Yahoo Finance
Biohaven stock slides on withdrawal of European marketing application - BioPharma Dive
Biohaven (BHVN) Withdraws EMA Application, U.S. Approval Crucial - GuruFocus
Biohaven (BHVN) Withdraws Troriluzole Application in Europe, Foc - GuruFocus
Biohaven (BHVN) Stock Drops After Withdrawal of EU Drug Applicat - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Biohaven Ltd. Stock Faces Turbulence Amid Strategic Shifts - TipRanks
Biohaven Ltd (NYSE:BHVN) Shares Surged 25.27% In A Week – But Will They Keep Going Up? - Marketing Sentinel
Biohaven Pharma stock tumbles after withdrawal of Dazluma application in EU By Investing.com - Investing.com South Africa
Biohaven Pharma stock tumbles after withdrawal of Dazluma application in EU - Investing.com UK
BHVN’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com
Biohaven Ltd (BHVN) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Jim Cramer Says Biohaven (BHVN) Is “Too Cheap” and He’s a Buyer at $21 - Insider Monkey
0.03%
0.49%
자본화:
|
볼륨(24시간):